Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic alterations in hepatocellular carcinoma: An update
Zhao-Shan Niu, Xiao-Jun Niu, Wenhong Wang
World Journal of Gastroenterology (2016) Vol. 22, Iss. 41, pp. 9069-9069
Open Access | Times Cited: 153

Showing 1-25 of 153 citing articles:

Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
Simmone D’souza, Keith C.K. Lau, Carla S. Coffin, et al.
World Journal of Gastroenterology (2020) Vol. 26, Iss. 38, pp. 5759-5783
Open Access | Times Cited: 187
Liver Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells
Germana Castelli, Elvira Pelosi, Ugo Testa
Cancers (2017) Vol. 9, Iss. 9, pp. 127-127
Open Access | Times Cited: 144
Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis
Hanyu Jiang, Jie Chen, Chunchao Xia, et al.
World Journal of Gastroenterology (2018) Vol. 24, Iss. 22, pp. 2348-2362
Open Access | Times Cited: 135
Tumor-Associated Neutrophils in Hepatocellular Carcinoma Pathogenesis, Prognosis, and Therapy
Konstantinos Arvanitakis, Ioannis Mitroulis, Georgios Germanidis
Cancers (2021) Vol. 13, Iss. 12, pp. 2899-2899
Open Access | Times Cited: 90
Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy
Xiaoxiao Ding, Qing-Ge Zhu, Shiming Zhang, et al.
Oncotarget (2017) Vol. 8, Iss. 33, pp. 55715-55730
Open Access | Times Cited: 89
Melatonin and circadian rhythms in liver diseases: Functional roles and potential therapies
Keisaku Sato, Fanyin Meng, Heather Francis, et al.
Journal of Pineal Research (2020) Vol. 68, Iss. 3
Open Access | Times Cited: 83
Experimental Models of Hepatocellular Carcinoma—A Preclinical Perspective
Alexandru Blidişel, Iasmina Marcovici, Dorina Coricovac, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3651-3651
Open Access | Times Cited: 57
Chronic Inflammation’s Transformation to Cancer: A Nanotherapeutic Paradigm
Sayed Sartaj Sohrab, Riya Raj, Amka Nagar, et al.
Molecules (2023) Vol. 28, Iss. 11, pp. 4413-4413
Open Access | Times Cited: 41
Temporal trends and patterns for early- and late-onset adult liver cancer incidence vary by race/ethnicity, subsite, and histologic type in the United States from 2000 to 2019
Mei‐Chin Hsieh, Kendra L. Ratnapradipa, Laura S. Rozek, et al.
Cancer Causes & Control (2025)
Open Access | Times Cited: 1
LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR‐24‐3p
Ji‐Chang Fan, Fei Zeng, Yiguan Le, et al.
Journal of Cellular Biochemistry (2017) Vol. 119, Iss. 8, pp. 6391-6397
Closed Access | Times Cited: 65
Overexpression of zinc finger protein 384 (ZNF 384), a poor prognostic predictor, promotes cell growth by upregulating the expression of Cyclin D1 in Hepatocellular carcinoma
Lifeng He, Xiaoxiao Fan, Yirun Li, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 6
Open Access | Times Cited: 60
<p>miR-1-3p suppresses proliferation of hepatocellular carcinoma through targeting SOX9</p>
Hao Zhang, Zhenya Zhang, Lili Gao, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 2149-2157
Open Access | Times Cited: 57
Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Miguel Sogbe, I. Bilbao, Francesco P. Marchese, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 2, pp. 177-190
Open Access | Times Cited: 8
Long noncoding RNA NNT-AS1 promotes hepatocellular carcinoma progression and metastasis through miR-363/CDK6 axis
Yebin Lu, Qin Jiang, Manyi Yang, et al.
Oncotarget (2017) Vol. 8, Iss. 51, pp. 88804-88814
Open Access | Times Cited: 54
Identifying Clonal Origin of Multifocal Hepatocellular Carcinoma and Its Clinical Implications
Diyang Xie, Hongkai Fan, Zhenggang Ren, et al.
Clinical and Translational Gastroenterology (2019) Vol. 10, Iss. 2, pp. e00006-e00006
Open Access | Times Cited: 46
Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profiles
Harpreet Kaur, Sherry Bhalla, Gajendra P. S. Raghava
PLoS ONE (2019) Vol. 14, Iss. 9, pp. e0221476-e0221476
Open Access | Times Cited: 46
Recent advances in the molecular mechanism of sex disparity in hepatocellular carcinoma (Review)
Yanmeng Li, Anjian Xu, Siyu Jia, et al.
Oncology Letters (2019)
Open Access | Times Cited: 44
p53 triggers mitochondrial apoptosis following DNA damage-dependent replication stress by the hepatotoxin methyleugenol
Max J. Carlsson, Anastasia S. Vollmer, Philipp Demuth, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 11
Open Access | Times Cited: 26
Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?
Daniele Fanale, Lidia Rita Corsini, R. Scalia, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 170, pp. 103597-103597
Closed Access | Times Cited: 24
Cholesterol overload in the liver aggravates oxidative stress-mediated DNA damage and accelerates hepatocarcinogenesis
Cristina Enríquez‐Cortina, Oscar Bello‐Monroy, Patricia Rosales-Cruz, et al.
Oncotarget (2017) Vol. 8, Iss. 61, pp. 104136-104148
Open Access | Times Cited: 47
Study on the mechanism of quercetin in Sini Decoction Plus Ginseng Soup to inhibit liver cancer and HBV virus replication through CDK1
Liyuan Hao, Shenghao Li, Guo Chen, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 6
Closed Access | Times Cited: 4
Liver cancer: Current and new drug delivery systems
Samson A. Adeyemi, Lindokuhle M. Ngema, Yahya E. Choonara
Elsevier eBooks (2025), pp. 1-13
Closed Access
Astrocyte Elevated Gene-1/Metadherin (AEG-1/MTDH):A Promising Molecular Marker and Therapeutic Target for Hepatocellular Carcinoma
Eva Davis, Ali Gawi Ermi, Devanand Sarkar
Cancers (2025) Vol. 17, Iss. 8, pp. 1375-1375
Open Access
DNA methylation-driven genes in hepatocellular carcinoma patients: insights into immune infiltration and prognostic implications
Zhi Zhang, Tongling Zhao, Weida Meng, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
miRNA-346 promotes proliferation, migration and invasion in liver cancer
Qiang Yu, Yang Xia, Weidong Duan, et al.
Oncology Letters (2017) Vol. 14, Iss. 3, pp. 3255-3260
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top